Home›Stock Screener›Remedium Lifecare

Remedium Lifecare Share Price Today | Stock Price & Remedium Lifecare Share Screener

REMLIFE Trading & Distributors
Live Share Price BSE
₹0.87
▲ 0.00 (0.00%)
2026-01-19 00:00:00

As of January 19, 2026, the live Remedium Lifecare share price (BSE: REMLIFE) is ₹0.87, unchanged from the previous close, with shares trading between ₹0.86 and ₹0.91 in today's trading session, and a 52-week range of ₹0.70–₹1.59. Check REMLIFE 52-week performance for the annual price range and momentum. Use the Remedium Lifecare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Remedium Lifecare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹265 and net income of ₹-2.

Remedium Lifecare Market Cap ₹77.57 Cr.
REMLIFE P/E Ratio (TTM) 40.50
Remedium Lifecare P/B Ratio 0.78
EPS (TTM) ₹0.05
Dividend Yield -
Debt to Equity 26.01
REMLIFE 52 Week High ₹1.59
Remedium Lifecare 52 Week Low ₹0.70
Operating Margin -
Profit Margin -0.75%
REMLIFE Revenue (TTM) ₹265.00
EBITDA -
Net Income ₹-2.00
Total Assets ₹1,720.00
Total Equity ₹44.00

Remedium Lifecare Share Price Chart

Track the current stock price of Remedium Lifecare with an interactive chart. Analyse REMLIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Remedium Lifecare stock quote in one place.

The quote of ₹0.87 sits between the 52-week low of ₹0.70 and the 52-week high of ₹1.59.

Remedium Lifecare Company Profile - Fundamental Screener

Screen Remedium Lifecare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for REMLIFE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Commercial Services sector and the Trading & Distributors industry, and it trades under ISIN INE549S01036.

Company Details

Classification

Sector Commercial Services
Industry Trading & Distributors
Sub-Sector Trading & Distributors
Segment E

Identifiers and Leadership

ISIN INE549S01036

Remedium Lifecare Balance Sheet Screener

Screen REMLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹1,720 against total liabilities of ₹1,720.

Latest statistics put total assets at ₹1,720 and shareholder funds at ₹44, with a leverage ratio of 26.01.

Item 2025

Assets

Total Assets 1,720
Current Assets 1,720
Fixed Assets 0

Liabilities

Total Liabilities 1,720
Current Liabilities 0
Non-Current Liabilities 0

Shareholders' Equity

Total Equity 44
Share Capital 40
Reserves & Surplus 4

Remedium Lifecare Income Statement Screener - Profit & Revenue Analysis

Screen Remedium Lifecare income statement and profit fundamentals. Analyze REMLIFE quarterly results. Remedium Lifecare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹265 and net profit was ₹-2, equal to earnings per unit of ₹-0.05.

In that period expenses were ₹265, interest cost ₹2 and tax ₹1. The next period listed, 2025-Jun, shows revenue of ₹117 and net profit of ₹5.

Item 2025-Mar 2025-Jun 2025-Sept

Revenue and Expenses

Revenue 265 117 114
Expenses 265 112 104

Operating Costs and Margins

EBITDA 0 5 11
Operating Profit % 0.00% 2.00% 7.00%
Depreciation 0 0 0
Interest 2 0 0

Profit and Earnings

Profit Before Tax -1 6 10
Tax 1 1 2
Net Profit -2 5 9
EPS -0.05 0.05 0.10

Remedium Lifecare Cash Flow Screener - Liquidity Fundamentals

Screen REMLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities used ₹1,135, and net cash flow was an inflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹1,136.

Item 2025-March

Cash from Operations and Investing

Operating Activities -1,135
Investing Activities 0

Financing and Net Cash

Financing Activities 1,136
Net Cash Flow 1

Remedium Lifecare Shareholding Pattern Screener

See Remedium Lifecare shareholding pattern with promoter, FII, and DII holdings. Check Remedium Lifecare promoter holding and ownership changes for REMLIFE on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 1.11%, foreign institutions 0.00%, domestic institutions 0.00% and the public 87.29%, spread across 110,422 shareholders.

The shareholder count was 110,422 in 2025-Mar, compared with 113,543 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Jul 2024-Sept

Promoter Holding

Promoter Holding 1.11% 1.13% 1.13% 1.13% 1.11% 1.11% 1.11% 1.11%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 1.70% 0.04% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 87.29% 78.39% 79.02% 81.29% 82.21% 83.33% 84.50% 85.01%
Other Holding 11.60% 20.48% 19.85% 15.88% 16.64% 15.56% 14.39% 13.87%
Shareholder Count 110,422 113,543 114,119 111,269 15,587 26,464 41,565 67,404

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Remedium Lifecare. Remedium Lifecare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Remedium Lifecare.

Remedium Lifecare Stock Index Membership - Nifty & Sensex

See which indices include Remedium Lifecare stock. Check REMLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Remedium Lifecare is not part of any tracked indices.
Only major market indices are tracked in our system.

Remedium Lifecare Market Events Screener - Corporate Actions

Get Remedium Lifecare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Remedium Lifecare stock events that may affect REMLIFE share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated .

It is followed by Change Of Name dated and Split dated .

Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 13.64%
Change Of Name NA 0.00%
2023-06-23 Split 5:10 0.00%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -14.47%
2025-08-04 2025-08-04 Quarterly Result Announcement NA 3.15%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 2.82%
2025-04-15 2025-04-15 Rights 61:50 0.65%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -7.14%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -2.35%
2024-07-05 2024-07-06 Bonus 3:1 29.04%
2024-06-26 2024-06-26 Annual General Meeting NA -16.45%
2024-02-23 2024-01-08 Split 1:5 0.00%
2023-07-28 Bonus 9:5 -

Remedium Lifecare Competitors Screener - Peer Stocks Comparison

Screen REMLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Commercial Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Redington 20,600 11.23 99,562 11.11% 1,821 38.55
Elitecon International 12,531 52.62 551 55040.00% 70 30.66
MMTC 10,331 48.82 263 28.63% 87 59.79
BN Agrochem 3,442 50.07 367 5071.83% 20 39.82
MSTC 3,358 8.20 388 -25.38% 407 41.73
Ravindra Energy 2,669 41.03 262 79.10% 23 44.97
Vintage Coffee & Beverages 2,241 37.85 313 136.92% 40 42.30
TCC Concept 2,138 44.68 90 14.72% 42 46.33
Creative Newtech 1,066 17.54 1,802 3.48% 53 45.95
Polo Queen Industrial And Fintech 1,010 373.00 81 15.16% 3 35.03

Remedium Lifecare Company Announcements - News & Reports Screener

Screen REMLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated December 22, 2025.

The next most recent announcements are dated December 15, 2025 and December 8, 2025.

Date Update Actions
2025-12-22 Closure of Trading Window -
2025-12-15 Announcement under Regulation 30 (LODR)-Change of Company Name -
2025-12-08 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2025-12-08 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2025-11-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-17 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2025-11-14 Results - Financial Results For Quarter And Half Year Ended September 30 2025 -
2025-11-14 Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2025 -
2025-11-10 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2025-11-06 Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Quarter And Half Year Ended 30.09.2025 -
2025-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-04 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2025-10-31 Appointment Of Mr. Rambhajan Vishwakarma And Mr. Vignesh Laxman Gawde -
2025-10-31 Board Meeting Outcome for Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 For Outcome Of Board Meeting Held On Friday 31St October 2025 -
2025-10-29 Announcement under Regulation 30 (LODR)-Resignation of Director -
2025-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-10-06 Announcement under Regulation 30 (LODR)-Resignation of Director -
2025-09-24 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-24 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-23 Closure of Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹0.87, within a 52-week range of ₹0.70 to ₹1.59. The P/E ratio is 40.50 and the P/B ratio is 0.78, with earnings per unit of ₹0.05. Market capitalisation stands at ₹77.57 Cr. The company operates in the Commercial Services sector, in the Trading & Distributors industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on January 24, 2026. This page covers 1 balance sheet periods, 3 income statement periods, 1 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.